MBL

Anti-CD318 (CDCP1) (Human) mAb

Product Code:
 
MBL-W128-3
Product Group:
 
Primary Antibodies
Supplier:
 
MBL
Host Type:
 
Mouse
Antibody Isotype:
 
IgG2b κ
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
1D3A1
Regulatory Status:
 
RUO
Target Species:
 
Human
Application:
 
Flow Cytometry
Shipping:
 
4°C
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
MBL-W128-3100 ul£345.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Applications:
FCM - 1-10 ug/mL
Background:
CUB domain-containing protein 1, also known as CDCP1 or CD318, is a transmembrane protein, which contains three extracellular CUB domains and acts as a substrate for Src family kinases. CDCP1 is involved in cell adhesion and cell matrix association. It is highly expressed in the skeletal muscle and colon. Upregulation of CDCP1 is observed in a number of human tumor cell lines as well as in colorectal cancer, breast carcinoma, and lung cancer.
Formulation:
1 mg/mL in PBS/50% glycerol, pH 7.2
Gene IDs:
Human: 64866
Immunogen Translated:
Human CD318 (CDCP1) expressed Ba/F3 transfectants generated from SST-REX (signal sequence trap by retrovirus-mediated expression screening).
Reactivity:
This antibody reacts with human CD318 (CDCP1) on Flow cytometry.
Source:
This antibody was purified from hybridoma culture supernatant by Protein A affinity column chromatography.
Target:
CD318 (CDCP1) (Human)

Documents

References

1) Bhatt, A. S., et. al., Oncogene 24, 5333-5343 (2005) 2) B?hring, H. J., et. al., Stem Cells 22, 334-343 (2004) 3) Scherl-Mostageer, M., et. al., Oncogene 20, 4402-4408 (2001) 4) Kojima, T. and Kitamura,T., Nat. Biotechnol. 17, 487-490 (1999)